NCT03471000 is a NA clinical trial of Short implants Treatment in Partial Edentulism, sponsored by Jakub Hadzik.

Who is sponsoring NCT03471000?

NCT03471000 is sponsored by Jakub Hadzik.

What drugs are being tested in NCT03471000?

Interventions in NCT03471000: Short implants Treatment, Regular implants Treatment.

What condition does NCT03471000 study?

NCT03471000 studies Partial Edentulism, Tooth Loss.

Is NCT03471000 still recruiting?

NCT03471000 is currently completed. Last updated 14 January 2020.

Last reviewed 2020-01-14 · How we verify

NCT03471000

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Influence of the Crown-implant Ratio on the Crestal Bone Level and Implant Secondary Stability

Completed NA Last updated 14 January 2020

What this trial tests

NA trial testing Short implants Treatment in Partial Edentulism in 30 participants. Completed in 1 January 2016.

Timeline

1 January 2012

Primary endpoint
1 January 2016

1 January 2016

Quick facts

Lead sponsor	Jakub Hadzik
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	30
Start date	1 January 2012
Primary completion	1 January 2016
Estimated completion	1 January 2016

Drugs / interventions tested

Short implants Treatment
Regular implants Treatment

Conditions studied

Partial Edentulism — all drugs for Partial Edentulism →
Tooth Loss — all drugs for Tooth Loss →

Sponsor

Jakub Hadzik

Who can join

18 and older, any sex, with Partial Edentulism or Tooth Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study was to determine whether implant length and the crown-to-implant (C/I) ratio influence implant stability and the loss of the surrounding marginal bone, and whether short implants can be used instead of sinus augmentation procedures.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

The Influence of the Crown-Implant Ratio on the Crestal Bone Level and Implant Secondary Stability: 36-Month Clinical Study.
Hadzik J, Krawiec M, Sławecki K, Kunert-Keil C, et al · · 2018 · cited 18× · PMID 29862269 · DOI 10.1155/2018/4246874
Short (6 mm) and Regular Dental Implants in the Posterior Maxilla-7-Years Follow-up Study.
Hadzik J, Kubasiewicz-Ross P, Nawrot-Hadzik I, Gedrange T, et al · · 2021 · cited 14× · PMID 33804340 · DOI 10.3390/jcm10050940

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03471000 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Jakub Hadzik
Last refreshed: 14 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03471000.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing